• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LINC02489 通过抑制 m6A 修饰增强紫杉醇敏感性,从而抑制卵巢癌细胞的迁移和侵袭。

LINC02489 with m6a modification increase paclitaxel sensitivity by inhibiting migration and invasion of ovarian cancer cells.

机构信息

Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.

Huaian Maternal and Child Health Hospital, Huaian City, Jiangsu Province, China.

出版信息

Biotechnol Genet Eng Rev. 2023 Oct;39(2):1128-1142. doi: 10.1080/02648725.2023.2167772. Epub 2023 Jan 26.

DOI:10.1080/02648725.2023.2167772
PMID:36703541
Abstract

The long non-coding RNA LINC02489 has been shown to be significantly downregulated in advanced ovarian cancer (OC). However, the function of LINC02489 remains unknown. This study aims to explain the role and mechanism of LINC02489 in OC. The expression of LINC02489 was examined by qRT-PCR in primary OC tissues. Additionally, MTT, wound healing, transwell, and flow cytometry assays were used to analyze the function of LINC02489. The mechanism of LINC02489 in OC was investigated by high-throughput RNA-sequencing, qRT-PCR, western blot, and N6-methyladenosine (m6A) meRIP. A total of 1101 and 827 genes are significantly down-regulated and up-regulated in metastatic and chemoresistant OC tissues. The expression of LINC02489 is decreased in metastatic and chemoresistant OC tissues compared with the primary OC tissues ( < 0.05). Overexpression of LINC02489 inhibits proliferation, invasion, and migration of drug-resistant OC cells. In the LINC02489 overexpressed chemoresistant SKOV3 cells, the m6A modified LINC02489 is significantly up-regulated. Furthermore, the expression of PKNOX2 is increased during overexpression of LINC02489, while the expression of PTEN and mTOR plummets. This study demonstrates that LINC02489 can inhibit the invasion and migration of chemoresistant OC cells by increasing its m6A modification and up-regulating PKNOX2 expression. In addition, LINC02489 regulates the invasion ability of OC cells through the PTEN/mTOR signaling pathway, thereby regulating the sensitivity of SKOV3 cells to paclitaxel. This result provides a potential therapeutic target for chemoresistant OC.

摘要

长链非编码 RNA LINC02489 在晚期卵巢癌(OC)中显示出明显下调。然而,LINC02489 的功能仍然未知。本研究旨在解释 LINC02489 在 OC 中的作用和机制。通过 qRT-PCR 检测原发性 OC 组织中 LINC02489 的表达。此外,还使用 MTT、划痕愈合、transwell 和流式细胞术检测分析 LINC02489 的功能。通过高通量 RNA-seq、qRT-PCR、western blot 和 N6-甲基腺苷(m6A)meRIP 研究 LINC02489 在 OC 中的机制。转移性和耐药 OC 组织中分别有 1101 个和 827 个基因显著下调和上调。与原发性 OC 组织相比,转移性和耐药 OC 组织中 LINC02489 的表达降低(<0.05)。过表达 LINC02489 可抑制耐药 OC 细胞的增殖、侵袭和迁移。在过表达 LINC02489 的耐药 SKOV3 细胞中,m6A 修饰的 LINC02489 显著上调。此外,过表达 LINC02489 可增加 PKNOX2 的表达,同时降低 PTEN 和 mTOR 的表达。本研究表明,LINC02489 通过增加其 m6A 修饰和上调 PKNOX2 的表达,抑制耐药 OC 细胞的侵袭和迁移。此外,LINC02489 通过 PTEN/mTOR 信号通路调节 OC 细胞的侵袭能力,从而调节 SKOV3 细胞对紫杉醇的敏感性。该结果为耐药 OC 提供了一个潜在的治疗靶点。

相似文献

1
LINC02489 with m6a modification increase paclitaxel sensitivity by inhibiting migration and invasion of ovarian cancer cells.LINC02489 通过抑制 m6A 修饰增强紫杉醇敏感性,从而抑制卵巢癌细胞的迁移和侵袭。
Biotechnol Genet Eng Rev. 2023 Oct;39(2):1128-1142. doi: 10.1080/02648725.2023.2167772. Epub 2023 Jan 26.
2
LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.LINC-PINT 通过靶向 miR-374a-5p 抑制卵巢癌细胞的增殖、迁移和侵袭。
Cell Biochem Funct. 2020 Dec;38(8):1089-1099. doi: 10.1002/cbf.3565. Epub 2020 Jul 7.
3
Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer.长链非编码 RNA PVT1 通过调节卵巢癌细胞中的 miR-133a 促进细胞增殖和侵袭。
Biomed Pharmacother. 2018 Oct;106:61-67. doi: 10.1016/j.biopha.2018.06.112. Epub 2018 Jun 26.
4
LncRNA KB-1471A8.2 Overexpression Suppresses Cell Proliferation and Migration and Antagonizes the Paclitaxel Resistance of Ovarian Cancer Cells.长链非编码 RNA KB-1471A8.2 过表达抑制卵巢癌细胞增殖和迁移并拮抗紫杉醇耐药性。
Cancer Biother Radiopharm. 2019 Jun;34(5):316-324. doi: 10.1089/cbr.2018.2698. Epub 2019 Mar 20.
5
Long non-coding RNA PVT1-mediated miR-543/SERPINI1 axis plays a key role in the regulatory mechanism of ovarian cancer.长链非编码 RNA PVT1 介导的 miR-543/SERPINI1 轴在卵巢癌的调控机制中起关键作用。
Biosci Rep. 2020 Jun 26;40(6). doi: 10.1042/BSR20200800.
6
HOTAIR promotes paclitaxel resistance by regulating CHEK1 in ovarian cancer.HOTAIR通过调控卵巢癌中的CHEK1来促进对紫杉醇的耐药性。
Cancer Chemother Pharmacol. 2020 Aug;86(2):295-305. doi: 10.1007/s00280-020-04120-1. Epub 2020 Aug 2.
7
Long non-coding RNA UCA1 promotes the progression of paclitaxel resistance in ovarian cancer by regulating the miR-654-5p/SIK2 axis.长链非编码 RNA UCA1 通过调控 miR-654-5p/SIK2 轴促进卵巢癌对紫杉醇耐药。
Eur Rev Med Pharmacol Sci. 2020 Jan;24(2):591-603. doi: 10.26355/eurrev_202001_20035.
8
N6-methyladenosine (m6A)-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation, migration, and invasion of gastric cancer via miR495-5p/RAB19 axis.N6-甲基腺苷(m6A)介导的长非编码 RNA LINC01320 的上调通过 miR495-5p/RAB19 轴促进胃癌的增殖、迁移和侵袭。
Bioengineered. 2021 Dec;12(1):4081-4091. doi: 10.1080/21655979.2021.1953210.
9
ERp57‑small interfering RNA silencing can enhance the sensitivity of drug‑resistant human ovarian cancer cells to paclitaxel.内质网蛋白57小干扰RNA沉默可增强耐药人卵巢癌细胞对紫杉醇的敏感性。
Int J Oncol. 2019 Jan;54(1):249-260. doi: 10.3892/ijo.2018.4628. Epub 2018 Nov 7.
10
Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.长链非编码 RNA-JPX 可预测卵巢癌患者的不良预后,并通过 PI3K/Akt/mTOR 信号通路促进肿瘤细胞增殖、侵袭和迁移。
Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8135-8144. doi: 10.26355/eurrev_201812_16505.

引用本文的文献

1
Emerging role of m6A modification in ovarian cancer: progression, drug resistance, and therapeutic prospects.m6A修饰在卵巢癌中的新作用:进展、耐药性及治疗前景
Front Oncol. 2024 Mar 13;14:1366223. doi: 10.3389/fonc.2024.1366223. eCollection 2024.
2
New insights into the interaction between m6A modification and lncRNA in cancer drug resistance.m6A 修饰与长链非编码 RNA 在癌症耐药性中相互作用的新见解。
Cell Prolif. 2024 Apr;57(4):e13578. doi: 10.1111/cpr.13578. Epub 2023 Nov 14.
3
LncRNA Promotes Myogenic Differentiation by Interacting with PKNOX2 to Upregulate in Porcine Satellite Cells.
LncRNA 通过与 PKNOX2 相互作用促进肌源性分化,从而上调猪卫星细胞中的 。
Int J Mol Sci. 2023 Apr 5;24(7):6773. doi: 10.3390/ijms24076773.